RecruitingPhase 2NCT06470048
A Clinical Study to Evaluate Ianalumab in Participants With Diffuse Cutaneous Systemic Sclerosis
Studying Diffuse cutaneous systemic sclerosis
Last synced from ClinicalTrials.gov
ℹ
Clinical trial records are synced from ClinicalTrials.gov through automated extraction.
Report missing dataKey facts
- Sponsor
- Novartis Pharmaceuticals
- Principal Investigator
- Novartis PharmaceuticalsNovartis Pharmaceuticals
- Intervention
- Placebo(drug)
- Enrollment
- 200 enrolled
- Eligibility
- 18-70 years · All sexes
- Timeline
- 2024 – 2030
Study locations (30)
- Arizona Arthritis and Rheumatology Research PLLC, Mesa, Arizona, United States
- UCLA, Los Angeles, California, United States
- Hoag Hospital, Newport Beach, California, United States
- Clinical Res Of W Florida, Clearwater, Florida, United States
- GNP Research, Cooper City, Florida, United States
- IRIS Research and Development, Plantation, Florida, United States
- Sarasota Arthritis Res Ctr, Sarasota, Florida, United States
- University of Chicago Hospitals, Chicago, Illinois, United States
- UMC New Orleans, New Orleans, Louisiana, United States
- Uni Of Michigan Health System, Ann Arbor, Michigan, United States
- Wayne State University, Detroit, Michigan, United States
- Clinical Research Inst of MI, Saint Clair Shores, Michigan, United States
- Hospital for Special Surgery, New York, New York, United States
- West Tennessee Research Institute, Jackson, Tennessee, United States
- Arthritis and Rheumatology Ins, Allen, Texas, United States
- +15 more locations on ClinicalTrials.gov
Primary source
Recruitment status, site addresses, contacts, and full eligibility criteria can change between syncs. Always verify with the trial team before planning travel or treatment.
Open NCT06470048 on ClinicalTrials.govOther trials for Diffuse cutaneous systemic sclerosis
Additional recruiting or active studies for the same condition.
- RECRUITINGPHASE1, PHASE2NCT07473154Controlling Hyperactive Immunity With Long-lived LymphocytesQuell Therapeutics Limited
- RECRUITINGPHASE1, PHASE2NCT06947473Umbilical Cord Blood CD19-BCMA CART Cell Therapy for SLE-LN, SSc, andpSS PAH.Beijing GoBroad Hospital
- RECRUITINGPHASE2NCT05029336Autologous Stem Cell Transplant (ASCT) for Autoimmune DiseasesStephan Grupp MD PhD
- RECRUITINGPHASE2NCT07047690A Study of Nemolizumab for the Treatment of Adults With Systemic SclerosisGalderma R&D
- RECRUITINGPHASE2NCT07287670EncompaSSc: Evaluation of MTX-474 in Participants With Diffuse Cutaneous Systemic Sclerosis (dcSSc)Mediar Therapeutics
- RECRUITINGNCT07256418Transcriptomic Study of Cutaneous Fibroblasts in SclerodermaCentre Hospitalier Universitaire Dijon
- RECRUITINGPHASE1NCT07295847A Study of AZD0120 in Autoimmune DiseasesAstraZeneca
- RECRUITINGNANCT07292961Investigating the Effectiveness of the Biopsychosocial Model-Based Exercise Approach in Children and Adults Diagnosed With SclerodermaHacettepe University